Alinity m HBV Application Specification File — Class II medical device recall Z-0883-2022
Ongoing recall by Abbott Molecular, Inc., reported 2022-04-13, distributed in AZ, CA, IL, IN, MA, MI, MO, NH…. There is a potential for misquantitation high results of negative samples.
| Recall number | Z-0883-2022 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abbott Molecular, Inc., Des Plaines, IL, United States |
| Recall initiated | 2022-03-04 |
| Classified | 2022-04-06 |
| Reported by FDA | 2022-04-13 |
| Distributed | AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, VA |
| Countries outside the US | AT, AU, BE, BR, CA, CH, CZ, DE, EE, ES, FR, GB, IL, IT, JP, KR, LV, MY, NL, NO, NZ, PK, PL, PT, RO, RU, SA, SE, SG, SI, SV, TH, TW, VN, ZA |
Product
Alinity m HBV Application Specification File (US and CE)
Reason for recall
There is a potential for misquantitation high results of negative samples.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0883-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.